List of Tables
Table 1. Global Medical Antifungal Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Medical Antifungal Agent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Medical Antifungal Agent Market Competitive Situation by Manufacturers in 2024
Table 4. Global Medical Antifungal Agent Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Medical Antifungal Agent Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Medical Antifungal Agent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Medical Antifungal Agent Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Medical Antifungal Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Medical Antifungal Agent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medical Antifungal Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medical Antifungal Agent, Product Type & Application
Table 12. Global Key Manufacturers of Medical Antifungal Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Antifungal Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Antifungal Agent as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Antifungal Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Medical Antifungal Agent Sales by Region (2020-2025) & (K Units)
Table 18. Global Medical Antifungal Agent Sales Market Share by Region (2020-2025)
Table 19. Global Medical Antifungal Agent Sales by Region (2026-2031) & (K Units)
Table 20. Global Medical Antifungal Agent Sales Market Share by Region (2026-2031)
Table 21. Global Medical Antifungal Agent Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Medical Antifungal Agent Revenue Market Share by Region (2020-2025)
Table 23. Global Medical Antifungal Agent Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Medical Antifungal Agent Revenue Market Share by Region (2026-2031)
Table 25. North America Medical Antifungal Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Medical Antifungal Agent Sales by Country (2020-2025) & (K Units)
Table 27. North America Medical Antifungal Agent Sales by Country (2026-2031) & (K Units)
Table 28. North America Medical Antifungal Agent Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Medical Antifungal Agent Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Medical Antifungal Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Medical Antifungal Agent Sales by Country (2020-2025) & (K Units)
Table 32. Europe Medical Antifungal Agent Sales by Country (2026-2031) & (K Units)
Table 33. Europe Medical Antifungal Agent Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Medical Antifungal Agent Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Medical Antifungal Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Medical Antifungal Agent Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Medical Antifungal Agent Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Medical Antifungal Agent Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Medical Antifungal Agent Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Medical Antifungal Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Medical Antifungal Agent Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Medical Antifungal Agent Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Medical Antifungal Agent Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Medical Antifungal Agent Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Medical Antifungal Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Medical Antifungal Agent Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Medical Antifungal Agent Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Medical Antifungal Agent Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Medical Antifungal Agent Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Medical Antifungal Agent Sales (K Units) by Type (2020-2025)
Table 51. Global Medical Antifungal Agent Sales (K Units) by Type (2026-2031)
Table 52. Global Medical Antifungal Agent Sales Market Share by Type (2020-2025)
Table 53. Global Medical Antifungal Agent Sales Market Share by Type (2026-2031)
Table 54. Global Medical Antifungal Agent Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Medical Antifungal Agent Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Medical Antifungal Agent Revenue Market Share by Type (2020-2025)
Table 57. Global Medical Antifungal Agent Revenue Market Share by Type (2026-2031)
Table 58. Global Medical Antifungal Agent Price (US$/Unit) by Type (2020-2025)
Table 59. Global Medical Antifungal Agent Price (US$/Unit) by Type (2026-2031)
Table 60. Global Medical Antifungal Agent Sales (K Units) by Application (2020-2025)
Table 61. Global Medical Antifungal Agent Sales (K Units) by Application (2026-2031)
Table 62. Global Medical Antifungal Agent Sales Market Share by Application (2020-2025)
Table 63. Global Medical Antifungal Agent Sales Market Share by Application (2026-2031)
Table 64. Global Medical Antifungal Agent Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Medical Antifungal Agent Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Medical Antifungal Agent Revenue Market Share by Application (2020-2025)
Table 67. Global Medical Antifungal Agent Revenue Market Share by Application (2026-2031)
Table 68. Global Medical Antifungal Agent Price (US$/Unit) by Application (2020-2025)
Table 69. Global Medical Antifungal Agent Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Medical Antifungal Agent Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Medical Antifungal Agent Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bayer Medical Antifungal Agent Product
Table 84. Bayer Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sanofi Medical Antifungal Agent Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Merck & Co Company Information
Table 91. Merck & Co Description and Business Overview
Table 92. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck & Co Medical Antifungal Agent Product
Table 94. Merck & Co Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Medical Antifungal Agent Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. MSD Manuals Company Information
Table 101. MSD Manuals Description and Business Overview
Table 102. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. MSD Manuals Medical Antifungal Agent Product
Table 104. MSD Manuals Recent Developments/Updates
Table 105. Abbott Company Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Abbott Medical Antifungal Agent Product
Table 109. Abbott Recent Developments/Updates
Table 110. Glenmark Company Information
Table 111. Glenmark Description and Business Overview
Table 112. Glenmark Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Glenmark Medical Antifungal Agent Product
Table 114. Glenmark Recent Developments/Updates
Table 115. Enzon Pharmaceuticals Company Information
Table 116. Enzon Pharmaceuticals Description and Business Overview
Table 117. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Enzon Pharmaceuticals Medical Antifungal Agent Product
Table 119. Enzon Pharmaceuticals Recent Developments/Updates
Table 120. Astellas Pharma Company Information
Table 121. Astellas Pharma Description and Business Overview
Table 122. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Astellas Pharma Medical Antifungal Agent Product
Table 124. Astellas Pharma Recent Developments/Updates
Table 125. Scynexis Company Information
Table 126. Scynexis Description and Business Overview
Table 127. Scynexis Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Scynexis Medical Antifungal Agent Product
Table 129. Scynexis Recent Developments/Updates
Table 130. Cidara Therapeutics Company Information
Table 131. Cidara Therapeutics Description and Business Overview
Table 132. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Cidara Therapeutics Medical Antifungal Agent Product
Table 134. Cidara Therapeutics Recent Developments/Updates
Table 135. Lucigen Corporation Company Information
Table 136. Lucigen Corporation Description and Business Overview
Table 137. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Lucigen Corporation Medical Antifungal Agent Product
Table 139. Lucigen Corporation Recent Developments/Updates
Table 140. Biosergen Company Information
Table 141. Biosergen Description and Business Overview
Table 142. Biosergen Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Biosergen Medical Antifungal Agent Product
Table 144. Biosergen Recent Developments/Updates
Table 145. F2G Company Information
Table 146. F2G Description and Business Overview
Table 147. F2G Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. F2G Medical Antifungal Agent Product
Table 149. F2G Recent Developments/Updates
Table 150. Sichuan Meidakang Pharmaceutical Company Information
Table 151. Sichuan Meidakang Pharmaceutical Description and Business Overview
Table 152. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product
Table 154. Sichuan Meidakang Pharmaceutical Recent Developments/Updates
Table 155. Chengdu Taihe Health Technology Company Information
Table 156. Chengdu Taihe Health Technology Description and Business Overview
Table 157. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Chengdu Taihe Health Technology Medical Antifungal Agent Product
Table 159. Chengdu Taihe Health Technology Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Medical Antifungal Agent Distributors List
Table 163. Medical Antifungal Agent Customers List
Table 164. Medical Antifungal Agent Market Trends
Table 165. Medical Antifungal Agent Market Drivers
Table 166. Medical Antifungal Agent Market Challenges
Table 167. Medical Antifungal Agent Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Antifungal Agent
Figure 2. Global Medical Antifungal Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Medical Antifungal Agent Market Share by Type: 2024 & 2031
Figure 4. Azoles Product Picture
Figure 5. Echinocandins Product Picture
Figure 6. Polyenes Product Picture
Figure 7. Allylamines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Medical Antifungal Agent Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Medical Antifungal Agent Market Share by Application: 2024 & 2031
Figure 11. Dermatophytosis
Figure 12. Aspergillosis
Figure 13. Candidiasis
Figure 14. Others
Figure 15. Global Medical Antifungal Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Medical Antifungal Agent Market Size (2020-2031) & (US$ Million)
Figure 17. Global Medical Antifungal Agent Sales (2020-2031) & (K Units)
Figure 18. Global Medical Antifungal Agent Average Price (US$/Unit) & (2020-2031)
Figure 19. Medical Antifungal Agent Report Years Considered
Figure 20. Medical Antifungal Agent Sales Share by Manufacturers in 2024
Figure 21. Global Medical Antifungal Agent Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Medical Antifungal Agent Players: Market Share by Revenue in Medical Antifungal Agent in 2024
Figure 23. Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Medical Antifungal Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Medical Antifungal Agent Sales Market Share by Country (2020-2031)
Figure 26. North America Medical Antifungal Agent Revenue Market Share by Country (2020-2031)
Figure 27. United States Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Medical Antifungal Agent Sales Market Share by Country (2020-2031)
Figure 30. Europe Medical Antifungal Agent Revenue Market Share by Country (2020-2031)
Figure 31. Germany Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Medical Antifungal Agent Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Medical Antifungal Agent Revenue Market Share by Region (2020-2031)
Figure 38. China Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Medical Antifungal Agent Sales Market Share by Country (2020-2031)
Figure 48. Latin America Medical Antifungal Agent Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Medical Antifungal Agent Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Medical Antifungal Agent Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Medical Antifungal Agent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Medical Antifungal Agent by Type (2020-2031)
Figure 58. Global Revenue Market Share of Medical Antifungal Agent by Type (2020-2031)
Figure 59. Global Medical Antifungal Agent Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Medical Antifungal Agent by Application (2020-2031)
Figure 61. Global Revenue Market Share of Medical Antifungal Agent by Application (2020-2031)
Figure 62. Global Medical Antifungal Agent Price (US$/Unit) by Application (2020-2031)
Figure 63. Medical Antifungal Agent Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
